This article from the British Journal of General Practice explores newly published guidelines by the Association of Coloproctology of Great Britain and Ireland (ACPGBI) and the British Society of Gastroenterology (BSG) on the use of faecal immunochemical testing (FIT) for patients presenting with symptoms suggestive of colorectal cancer (CRC).

With increasing pressure on endoscopy services and a need for more effective triage in primary care, FIT is positioned as a valuable diagnostic tool to help identify high-risk patients and reduce unnecessary referrals. The guidance, endorsed by NHS England, aims to support GPs in safely integrating FIT into routine practice while addressing concerns around clinical responsibility and diagnostic accuracy.